Cyteir Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.33
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.38
|
0.00
|
0.38
|
100.00%
|
|
2022-12-31
|
-0.37
|
0.00
|
0.37
|
100.00%
|
|
2022-09-30
|
-0.41
|
-0.31
|
0.10
|
24.39%
|
|
2022-06-30
|
-0.44
|
-0.34
|
0.10
|
22.73%
|
|
2022-03-31
|
-0.39
|
-0.40
|
-0.01
|
-2.56%
|
|
2021-12-31
|
-0.39
|
-0.34
|
0.05
|
12.82%
|
|
2021-09-30
|
-0.36
|
-0.33
|
0.03
|
8.33%
|
|
2021-06-30
|
-1.46
|
-4.83
|
-3.37
|
-230.82%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.05
|
|
2021-12-31
|
-6.50
|
|
2020-12-31
|
-3.40
|
|
2019-12-31
|
-4.20
|